Botulinum toxin type A - Hyperhidrosis
You are here : Home > Formulary Search > Botulinum toxin type A - Hyperhidrosis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Injection
Formulary Status :
Associated Icons :
NFD1
Restrictions / Comments :
Documentation
PAD Profile
ChemicalSubstance :
Botulinum toxin type A
Indication :
Hyperhidrosis
Group Name :
Keywords :
Brand Names Include :
Botox
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Botulinum toxin type A is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Hyperhidrosis.
Committee Recommendations (1)
Botulinum toxin A is not routinely supported for the treatment of primary hyperhidrosis. If an individual patient demonstrates exceptional clinical circumstances then the clinician can submit an individual funding request (IFR) for consideration in line with Surrey Collaborative CCG’s operating procedure for dealing with IFRs.
Botulinum toxin for hyperhidrosis will be considered BLACK (not recommended for use in any health setting across Surrey and North West Sussex health economy) on the traffic light system.
Botulinum toxin for hyperhidrosis will be considered BLACK (not recommended for use in any health setting across Surrey and North West Sussex health economy) on the traffic light system.